pca 4230 has been researched along with calcimycin in 1 studies
| Studies (pca 4230) | Trials (pca 4230) | Recent Studies (post-2010) (pca 4230) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 11,946 | 40 | 444 |
| Protein | Taxonomy | pca 4230 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aragonés, MD; Catalán, RE; Garde, E; Hernández, F; Lombardía, M; Martínez, AM | 1 |
1 other study(ies) available for pca 4230 and calcimycin
| Article | Year |
|---|---|
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug.
Topics: Animals; Blood Platelets; Blood Proteins; Calcimycin; Cytoplasmic Granules; Dihydropyridines; Fibrinolytic Agents; Phosphorylation; Platelet Activating Factor; Rabbits; Thrombin | 1994 |